(Nanowerk Spotlight) Precision in drug delivery has long posed a significant challenge to the medical field. Relying on the body’s circulatory system to transport medications often results in ...

Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top those medicines, AbbVie has secured rights to an early-clinical drug that works ...